Protagonist's pipeline leverages its proprietary Vectrix platform to target obesity, hematology, and inflammation. Find out ...
In almost every anime and manga, the main antagonist is almost equally as responsible as the main protagonist in moving the narrative forward. But there are some shows where the imbalance of power ...
ICOTYDE is the first and only IL-23R targeted oral peptide that delivers complete skin clearance and a favorable safety profile in a once-daily pill ...
Protagonist Therapeutics Inc. has selected PN-881, an oral peptide interleukin-17 (IL-17) antagonist, as a development candidate for the treatment of immune-mediated skin diseases.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results